Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.17 (
CaMKII
)
4,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The human tyrosine phosphatase (p54(cdc25-c)) is activated by phosphorylation at mitosis entry. The phosphorylated p54(cdc25-c) in turn activates the p34-cyclin B protein kinase and triggers mitosis. Although the active p34-cyclin B protein kinase can itself phosphorylate and activate p54(cdc25-c), we have investigated the possibility that other kinases may initially trigger the phosphorylation and activation of p54(cdc25-c). We have examined the effects of the calcium/calmodulin-dependent protein kinase (
CaM kinase II
) on p54(cdc25-c). Our in vitro experiments show that
CaM kinase II
can phosphorylate p54(cdc25-c) and increase its phosphatase activity by 2.5-3-fold. Treatment of a synchronous population of HeLa cells with KN-93 (a water-soluble inhibitor of
CaM kinase II
) or the microinjection of AC3-I (a specific peptide inhibitor of
CaM kinase II
) results in a cell cycle block in G2 phase. In the KN-93-arrested cells, p54(cdc25-c) is not phosphorylated, p34(cdc2) remains tyrosine phosphorylated, and there is no increase in
histone H1
kinase activity. Our data suggest that a calcium-calmodulin-dependent step may be involved in the initial activation of p54(cdc25-c).
...
PMID:Calcium/calmodulin-dependent phosphorylation and activation of human Cdc25-C at the G2/M phase transition in HeLa cells. 1007 93
Ca(2+)/calmodulin-dependent protein kinase (CaMK) IV is a multifunctional Ser/Thr protein kinase that is predominantly expressed in the nuclei of neurons.
CaMKIV
consists of a catalytic domain and a regulatory (Ca(2+)/calmodulin binding and autoinhibitory) domain, which are located in the N-terminal and central regions, respectively. Here, we identified the zebrafish homologue of
CaMKIV
(zCaMKIV) on the basis of biochemical characterization. zCaMKIV showed similar biochemical properties as well as tissue and subcellular distributions to rat
CaMKIV
(rCaMKIV). However, zCaMKIV had a fairly small size with a molecular mass of about 40 kDa, and was devoid of a region corresponding to the C-terminal domain of rCaMKIV. Since zCaMKIV is composed of regions that are nearly equivalent to only a catalytic and a regulatory domain, it should represent a minimum size homologue possessing
CaMKIV
function. zCaMKIV and rCaMKIV differed in their substrate specificities, since rCaMKIV preferred
histone H1
over myelin basic protein, while zCaMKIV did not. Moreover, zCaMKIV was more readily dephosphorylated by zebrafish nuclear CaMK phosphatase (CaMKP-N) than rCaMKIV. These results suggest that the C-terminal region of
CaMKIV
plays a role in interacting with its target and modulator proteins.
...
PMID:A minimum size homologue of Ca2+/calmodulin-dependent protein kinase IV naturally occurring in zebrafish. 2019 Feb 69
<< Previous
1
2